Crossref
In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice
American Journal of Biomedical Sciences · 2022-01 · 29-38
DOI: 10.5099/aj220100030 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biomedical Sciences, 2022-01. Verfasst von Elias Adikwu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Adikwu, E., Igono, S. A., & Ebong, N. O. (2022). In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice. American Journal of Biomedical Sciences, 29-38. https://doi.org/10.5099/aj220100030
Vancouver
Adikwu E, Igono SA, Ebong NO. In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice. American Journal of Biomedical Sciences. 2022:29-38. doi:10.5099/aj220100030
BibTeX
@article{Adikwu2022,
author = {Adikwu, Elias and Igono, Simeon Ajeka and Ebong, Nwakaego Omonigho},
title = {In-vivo Antiplasmodial Impact of Dihydroartemisinin-Piperaquine-Clindamycin on Plasmodium berghei-Infected Mice},
journal = {American Journal of Biomedical Sciences},
year = {2022},
pages = {29--38},
doi = {10.5099/aj220100030}
}
EUVIMED